Co-targeting of HMG-Co-A Reductase and Cycloxygenase-2 for the Treatment of Non-small Cell Lung Cancer

Ashutosh Sharma; Ammu V V V Ravi Kiran; Praveen T Krishnamurthy

doi:10.34172/apb.2024.026

Co-targeting of HMG-Co-A Reductase and Cycloxygenase-2 for the Treatment of Non-small Cell Lung Cancer

Adv Pharm Bull. 2024 Oct;14(3):496-497. doi: 10.34172/apb.2024.026. Epub 2024 Jan 13.

Authors

Ashutosh Sharma¹, Ammu V V V Ravi Kiran¹, Praveen T Krishnamurthy¹

Affiliation

¹ Department of Pharmacology, JSS College of Pharmacy (JSS Academy of Higher Education & Research), Ooty, The Nilgiris, Tamil Nadu 643001, India.

No abstract available

Grants and funding

The authors would like to thank the Department of Science and Technology-Fund for Improvement of Science and Technology Infrastructure in Universities and Higher Educational Institutions (DST-FIST), New Delhi for infrastructure support (Grant No. SR/FST/LSI-574/2013).